A large-scale study, presented at UEG Week 2026, has identified distinct antibody patterns up to 10 years before the diagnosis of inflammatory bowel disease (IBD), potentially opening new avenues for ...

Rituximab has been linked to a higher risk of inflammatory bowel disease than other MS therapies. Explore what it means for ...

The first U.K.-wide analysis of bowel screening for patients with inflammatory bowel disease (IBD) has identified ...

A major study has uncovered hidden warning signs of inflammatory bowel disease in the blood up to 10 years before diagnosis.

Scientists have identified a hidden cause of inflammatory bowel disease: antibodies that disable the immune system’s natural ...

People with multiple sclerosis (MS) who are treated with rituximab have an increased risk of developing inflammatory bowel ...

In 2009, Michael Sheridan was diagnosed with ulcerative colitis, a type of inflammatory bowel disease. Through “trial and error,” he eventually found ways to control his symptoms. Suddenly in 2019, ...

Gilead Sciences (GILD) stock gains as bowel disease drug emvistegrast succeeds in a mid-stage trial. Read more here.

Add Yahoo as a preferred source to see more of our stories on Google. Rising colorectal cancer rates among young adults are making under-50s anxious — but the disease remains rare in the age group.

Certain lifestyle factors can help reduce the risk of developing the disease. Dr. Michael Shusterman, a gastrointestinal oncologist, does these three easy things to help lower his risk. Colon cancer ...